Which CanSino is better?
As vaccination in various countries enters a full-scale stage, the CanSino vaccine has attracted much attention. But what are the pros and cons that come to mind when people consider getting the CanSino vaccine? Below, this article will analyze which CanSino is better from four aspects: vaccine efficacy, safety, applicable groups and vaccination status.
Comparison of medicinal efficacy
The CanSino vaccine, jointly developed by Beijing Kangchen Pharmaceutical Co., Ltd. and Wuhan Institute of Biological Products Co., Ltd., is an inactivated COVID-19 vaccine. Vaccine efficacy is an important indicator to measure whether a vaccine is safe and effective. According to official data, “On January 5, 2021, Sinovac Zhongwei announced the results of a randomized, double-blind, placebo-controlled Phase III clinical trial showing that the effectiveness of its new coronavirus inactivated vaccine was 91.25%. In 2021 On February 4, Changchun Changsheng announced that its reference materials showed that the Phase II and Phase III clinical study results and quality data of its new coronavirus inactivated vaccine all met relevant requirements.”
However, the results of the Phase III clinical trial data evaluation of the CanSino vaccine have not yet been made public, so the efficacy of the CanSino vaccine cannot be directly compared. However, the CanSino vaccine has performed well in terms of safety. The side effects of the vaccine are relatively low, mainly manifesting as local pain and fever, and there have been no reports of serious adverse reactions. Therefore, the CanSino vaccine has excellent performance in terms of efficacy and safety.
Security comparison
In addition to efficacy, people also consider safety when choosing a vaccine. In this regard, the CanSino vaccine has also received great attention internationally. According to data provided by the World Health Organization (WHO) about the CanSino vaccine, there were zero reported serious adverse reactions in the Phase II clinical trials of the CanSino vaccine, indicating that it performed well in terms of safety.
At the same time, the data on the CanSino vaccine in China also shows that the side effects of this vaccine are very low. Globally, although there are a small number of serious adverse reactions reported, the overall safety of the CanSino vaccine is still at a high level compared with other vaccines, and it is a vaccine with high availability.
Comparison of applicable groups
Due to different physical conditions and ages of different people, the suitability of a vaccine also varies. In this regard, the CanSino vaccine is suitable for a wide range of people, including women and men over 12 years old, young people and the elderly, etc.
Other vaccines, such as vaccines based on mRNA technology such as Pfizer and Moderna, are only suitable for adults. Because young people and children were not adequately studied during the research and production of this type of vaccine.
Comparison of vaccination status
Finally, the current status of vaccination with the CanSino vaccine also needs to be considered. Although there is currently no comprehensive compulsory vaccination policy in China, issues such as vaccine shortage and vaccination sequence have also restricted the promotion of vaccines.
In this regard, the CanSino vaccine also faces some obstacles. Due to the order and tension of vaccination, many people can only be vaccinatedTo other types of vaccines, the CanSino vaccine is not an option. However, this does not affect the good efficacy and safety of the CanSino vaccine, it was just missed during the distribution process. Therefore, the CanSino vaccine remains a vaccine worthy of trust and promotion.
Summary
Judging from the four aspects of the vaccine\’s efficacy, safety, applicable groups and vaccination status, the performance of the CanSino vaccine is excellent in terms of efficacy and safety, and is applicable to a wide age range. However, it is subject to the problem of vaccination tension and sequence. So overall, the CanSino vaccine is a good vaccine for people to choose to use.
